Effect of fusidic acid on pancreatic islet allograft rejection.
We examined in fully mismatched rats, the survival of pancreatic islet allografts in recipients treated with either fusidic acid (FA), an antistaphyllococcal antibiotic that has been shown to possess an immunosuppressive effect in vitro and in vivo, or cyclosporin-A (CsA). Islets were isolated by collagenase digestion, separated from acinar tissue by handpicking under a dissecting microscope and transplanted into the liver by portal vein injection of streptozotocin(STZ)-induced diabetic rats. The results indicated that while a temporary immunosuppression with CsA achieved an indefinite islet allograft survival, FA administered to recipients daily was not able to prevent islet allograft rejection across a major histocompatibility barrier. We conclude that despite the fact that fusidic acid has been claimed to act as an-immunosuppressant drug in vitro with effects similar to those of CsA, unlike CsA, FA given either orally or by s.c. injection was not effective to prolong islet allograft survival in vivo.
Mendola
J F
JF
Department of Surgery, Hospital Clínic of Barcelona, Spain.
Corominola
H
H
Esmatjes
E
E
Saenz
A
A
Fernandez-Cruz
L
L
Gomis
R
R
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D005672:Fusidic Acid / Q000494:pharmacology*; D006084:Graft Rejection / Q000378:metabolism*; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology; D016381:Islets of Langerhans Transplantation; D051381:Rats; D011917:Rats, Inbred Lew; D017208:Rats, Wistar
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D005672:Fusidic Acid